Chimeric hepatitis E virus-like particle as a carrier for oral-delivery
Highlights ► Sequence insertion at antigenic domain of HEV-VLP does not interfere with icosahedral assembly. ► Sequence insertion induces conformational changes at HEV antigenic domain leading to deterioration in antibody-binding. ► Sequence insertion introduces a trypsin cleavage site in the recomb...
Gespeichert in:
Veröffentlicht in: | Vaccine 2013-01, Vol.31 (2), p.417-424 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights ► Sequence insertion at antigenic domain of HEV-VLP does not interfere with icosahedral assembly. ► Sequence insertion induces conformational changes at HEV antigenic domain leading to deterioration in antibody-binding. ► Sequence insertion introduces a trypsin cleavage site in the recombinant HEV capsid protein. ► The chimeric VLP remains intact after trypsin cleavage. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.10.073 |